干扰素－α联合拉米夫定治疗慢性乙型肝炎临床疗效分析(2)
 |
| 第1页 |
参见附件(372KB，3页)。
responseuponadeno-associated virus (AAV) vector delivery into dendritic cells[J]. J Viral Hepat，2006，13(9)：605.
[4]Daza P，Banda R，Misoya K，et al. The impact of routine infant im-munization with Haemophilus influenzae type b conjugate vaccine in Malawi， a country with high human immunodeficiency virus preva-lence[J]. Vaccine，2006，24(37-39): 6232.
[5]Kwon CH，Suh KS，Yi NJ，et al. Long-term protection against hep-atitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation[J].Pediatr Transplant，2006， 10(4)：479.
[6]何文生.干扰素的临床应用[J]. 现代医药卫生，2006，22(10):1478.
[7]郇述玲，侯青顺，王德欣，等. 乙型肝炎病毒基因型用干扰素α-2b联合苦参素治疗的临床研究[J]. 现代医药卫生，2006，22(24)：3720.
[8]Martinot PM，Comanor L，Minor JM，et al. Accurate model predicting sustained response at week 4 of therapywithpegylatedinterferon with ribavirin in patients with chronic hepatitis C[J]. J Viral Hepat，2006，13(10)：701.
[9]Itsui Y，Sakamoto N，Kurosaki M，et al. Expressional screening of in-terferon-stimulated genes for antiviralactivityagainsthepatitis C virus replication[J]. J Viral Hepat，2006，13(10): 690.
[10]Munoz H，Arroyo J，Torres EA，et al. Response to combination ther-apy of interferon alfa-2b plus ribavirin in Hispanics with chronic hepatitis C[J]. PR Health Sci J，2004，23(2S): 61.
[11]Zheng S，Chen Y，Liang T，et al. Prevention of hepatitis B recurrenceafter liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis[J]. Liver Transpl，2006，12(2)：253.
收稿日期：2007-03-15
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文。
[ 上 页 ]
您现在查看是摘要介绍页，详见PDF附件(372KB，3页)。